Precigen (PGEN) Other financing activities (2012 - 2026)
Precigen's (PGEN) quarterly Other financing activities came in at $255000.0 in Q1 2026, up 70.0% year-on-year from $150000.0 in Q1 2025, and up 82.14% on a QoQ basis from $140000.0 in Q4 2025.
Precigen (PGEN) Other financing activities (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 12 years of Other financing activities data on file, last reported at $255000.0 in Q1 2026.
- On a quarterly basis, Other financing activities rose 70.0% year-over-year to $255000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 163.51% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 247.4% from the prior year.
- Other financing activities for Q1 2026 stood at $255000.0, up from $140000.0 in the prior quarter.
- Over the last five years, Other financing activities for PGEN reached as high as $839000.0 in Q3 2025 and fell as low as $1000.0 in Q1 2022.
- Historically, Other financing activities has averaged $225500.0 across 4 years, with a median of $145000.0 in 2025.
- Across the five-year window, Other financing activities slumped 99.1% in 2022 and soared 185.37% in 2025, its largest moves.
- Year by year, Other financing activities stood at $1000.0 in 2022, then surged by 29300.0% to $294000.0 in 2024, then sank by 52.38% to $140000.0 in 2025, then surged by 82.14% to $255000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $255000.0 in Q1 2026, $140000.0 in Q4 2025, and $839000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255,000.00 |
| Mar 31, 2026 | 255,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 839,000.00 |
| Sep 30, 2025 | 839,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Sep 30, 2024 | 294,000.00 |
| Sep 30, 2024 | 294,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Sep 30, 2021 | 351,000.00 |
| Sep 30, 2021 | 351,000.00 |
| Jun 30, 2021 | 141,000.00 |
| Jun 30, 2021 | 141,000.00 |